177A
Kohjin Bio Co.,Ltd.
コージンバイオ
- Industry
- Chemicals
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2024
4,770,096
Mar 2025
5,206,287
Operating profit(thousand JPY)
Mar 2024
596,822
Mar 2025
991,135
Operating profit margin(%)
Mar 2024
12.51
Mar 2025
19.04
Profit before tax(thousand JPY)
Mar 2024
635,601
Mar 2025
1,015,300
Profit(thousand JPY)
Mar 2024
384,978
Mar 2025
794,759
Total assets(thousand JPY)
Mar 2024
6,589,322
Mar 2025
9,066,648
Cash and cash equivalents(thousand JPY)
Mar 2024
1,726,936
Mar 2025
2,949,267
Cash flows from operating activities(thousand JPY)
Mar 2024
823,681
Mar 2025
915,551
Cash flows from investing activities(thousand JPY)
Mar 2024
-577,354
Mar 2025
-1,090,901
Cash flows from financing activities(thousand JPY)
Mar 2024
-1,348
Mar 2025
1,376,032
Return on equity(%)
Mar 2024
12.1
Mar 2025
17.4
Equity ratio(%)
Mar 2024
50.7
Mar 2025
63.8
Earnings per share(JPY per share)
Mar 2024
92.43
Mar 2025
157.57
Net assets per share(JPY per share)
Mar 2024
802.5
Mar 2025
1,131.12
Dividend per share(JPY per share)
Mar 2024
14
Mar 2025
24
Payout ratio(%)
Mar 2024
15.15
Mar 2025
15.23
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.